Literature DB >> 23689751

Immunotherapy: Adoptive cell therapy simplified.

Rebecca Kirk.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23689751     DOI： 10.1038/nrclinonc.2013.85

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  2 in total

1.  Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma.

Authors:  Mark E Dudley; Colin A Gross; Robert P T Somerville; Young Hong; Nicholas P Schaub; Shannon F Rosati; Donald E White; Debbie Nathan; Nicholas P Restifo; Seth M Steinberg; John R Wunderlich; Udai S Kammula; Richard M Sherry; James C Yang; Giao Q Phan; Marybeth S Hughes; Carolyn M Laurencot; Steven A Rosenberg
Journal:  J Clin Oncol       Date:  2013-05-06       Impact factor: 44.544

2.  Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells.

Authors:  Paul F Robbins; Yong-Chen Lu; Mona El-Gamil; Yong F Li; Colin Gross; Jared Gartner; Jimmy C Lin; Jamie K Teer; Paul Cliften; Eric Tycksen; Yardena Samuels; Steven A Rosenberg
Journal:  Nat Med       Date:  2013-05-05       Impact factor: 53.440
  2 in total
  2 in total

Review 1.  Trial Watch: Adoptive cell transfer for oncological indications.

Authors:  Fernando Aranda; Aitziber Buqué; Norma Bloy; Francesca Castoldi; Alexander Eggermont; Isabelle Cremer; Wolf Hervé Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-05-05       Impact factor: 8.110

Review 2.  Trial Watch: Adoptive cell transfer for anticancer immunotherapy.

Authors:  Fernando Aranda; Erika Vacchelli; Florine Obrist; Alexander Eggermont; Jérôme Galon; Wolf Hervé Fridman; Isabelle Cremer; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-05-01       Impact factor: 8.110
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.